Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Each study has a usefulness score out of 100 (rubric version 4.0). Tap a score to see what makes it up.

Highest usefulness score first. Studies without a score come last.

  1. Heart rate response and recovery during exercise and dementia risk: a prospective UK biobank study

    ✓ Peer-reviewed alzhub usefulness score 44 out of 100. Scientific Reports 2025-11-03 Long-term cohort studies

    The heart rate response/recovery (HRR) index, a common indicator for cardiovascular health during exercise, has been linked with neurocognitive disorders and mortality.

    Why it matters

    This study found that a higher heart rate response/recovery index and recovery ratio were associated with reduced risk of all-cause dementia but not with Alzheimer's disease or vascular dementia, and were correlated with slower cognitive decline in some domains. It suggests that cardiovascular fitness during exercise may be linked to dementia risk, but it does not show that improving fitness prevents dementia.

  2. Expanding Prior Authorization in Traditional Medicare—The WISeR Model

    ✓ Peer-reviewed alzhub usefulness score 44 out of 100. JAMA 2025-10-28 Health systems and care delivery

    This Viewpoint discusses the Wasteful and Inappropriate Service Reduction (WISeR) model, a new payment model announced by the Centers for Medicare & Medicaid Services Innovation Center to broaden prior authorization in traditional Medicare.

    Why it matters

    This viewpoint discusses the Wasteful and Inappropriate Service Reduction model, a new payment model to broaden prior authorization in traditional Medicare. It contains no research findings on treating, curing, or preventing Alzheimer's disease.

  3. AI-Based Severity Classification of Dementia Using Gait Analysis

    ✓ Peer-reviewed alzhub usefulness score 44 out of 100. Sensors 2025-10-02 Digital health tools

    This study aims to explore the utility of artificial intelligence (AI) in classifying dementia severity based on gait analysis data and to examine how machine learning (ML) can address the limitations of conventional statistical approaches.

    Why it matters

    A support vector machine classifier used gait parameters to categorize dementia severity in a small sample of 34 people with mild cognitive impairment, 25 with mild dementia, 26 with moderate dementia, and 54 healthy controls. The findings highlight the promise of AI-based tools for diagnosis, not for treating, curing, or preventing Alzheimer's disease.

  4. Role of PCPs in diagnosing dementia in traditional Medicare and Medicare Advantage

    ✓ Peer-reviewed alzhub usefulness score 44 out of 100. Alzheimer s & Dementia 2025-10-01 Health systems and care delivery

    Among a matched sample of 15,410,030 beneficiaries, accounting for both provider and patient characteristics, the incident dementia diagnosis rate was 0.11 percentage points lower for MA beneficiaries compared to TM beneficiaries attributed to the same PCP.

    Why it matters

    This study found that Medicare Advantage beneficiaries were slightly less likely to receive a new dementia diagnosis than similar traditional Medicare beneficiaries seen by the same primary care provider, and were less likely to see dementia specialists. It is about diagnosis patterns, not about treating, curing, or preventing Alzheimer's disease.

  5. Population intervention models of racial ethnic disparities in cognitive outcomes from cardiometabolic risk factors – HABS-HD

    ✓ Peer-reviewed alzhub usefulness score 44 out of 100. Alzheimer s Research & Therapy 2025-10-01 Disparities

    NHB Hispanic, and NHW participants prevalences were APOE ε4 (32.2%, 27.4%, 17.6%), diabetes (26.1%, 35.0%, 13.9%), hypertension (79.0%, 63.6%, 58.2%), obesity (56.8%, 50.3%, 38.5%), and tobacco dependence (12.9%, 7.5%, 3.9%).

    Why it matters

    This study found that diabetes, hypertension, APOE ε4, and tobacco dependence each independently predicted lower cognitive performance, and that hypothetically eliminating diabetes and hypertension yielded the largest predicted improvements, especially among non-Hispanic Black and Hispanic participants. The authors suggest population-level interventions targeting diabetes and hypertension could narrow cognitive deficits, but these are modeled projections, not tested treatments.

  6. Social Disparities, Delirium Occurrence, and Related Outcomes Among Hospitalized Older Adults

    ✓ Peer-reviewed alzhub usefulness score 44 out of 100. Journal of the American Geriatrics Society 2025-09-30 Risk factors

    A total of 260,200 older adults were screened for delirium (median [IQR] age in years: 78.0 [74.0-84.0]; female: 143,402 [55.1%]; non-Hispanic Black: 40,737 [15.8%]; Hispanic: 30,760 [11.9%]; median [IQR] Area Deprivation Index: 4.0 [2.0-6.0]; median [IQR] Charlson Comorbidity Index: 10.0 [8.0-13.0]).

    Why it matters

    Among 260,200 hospitalized older adults screened for delirium, this study found higher odds of delirium for non-Hispanic Black and Hispanic patients, those in higher Area Deprivation Index neighborhoods, and those with prior dementia. It suggests that social marginalization should be considered an important factor in delirium risk stratification.

  7. Associations of adherence to a healthy sleep pattern with the dementia risk in the UK biobank

    ✓ Peer-reviewed alzhub usefulness score 44 out of 100. Alzheimer s Research & Therapy 2025-09-30 Long-term cohort studies

    During a median follow-up of 13.8 years, 3,035 incident dementia cases were recorded, including 1,304 Alzheimer's disease (AD) cases and 597 vascular dementia (VD) cases.

    Why it matters

    In this UK Biobank cohort, higher adherence to a healthy sleep pattern was linked to lower dementia risk, and this benefit was partly mediated by preserved grey and white matter integrity. The authors suggest improving overall sleep behaviours may support brain structure and lower dementia risk, but the study is observational.

  8. Risk factor analysis of cognitive frailty in older adults with type 2 diabetes mellitus: a cross-sectional study

    ✓ Peer-reviewed alzhub usefulness score 44 out of 100. Frontiers in Aging Neuroscience 2025-09-25 Risk factors

    The prevalence of CF was 24.3%. Cerebrovascular disease (OR: 2.39, 95% CI: 1.44-3.97) and peripheral arterial disease (OR: 1.74, 95% CI: 1.03-2.95) were significant risk factors, while higher education (OR 0.85, 95% CI 0.76-0.94) and later diabetes onset (OR: 0.93, 95% CI: 0.88-0.98) were protective.

    Why it matters

    This cross-sectional study found that cerebrovascular disease and peripheral arterial disease were risk factors for cognitive frailty in older adults with type 2 diabetes, while higher education and later diabetes onset were protective. Because it is cross-sectional, it cannot show cause and effect or that managing these conditions prevents cognitive frailty.

  9. The National Dementia Workforce Study: The Plan for Organization Sample Frames and Data Collection

    ✓ Peer-reviewed alzhub usefulness score 44 out of 100. Journal of the American Geriatrics Society 2025-09-04 Long-term cohort studies

    The National Dementia Workforce Study was designed to improve our understanding of the individuals and systems who care for people with dementia, but designing and implementing such a study is challenging due to the large number of patient care organizations, clinical and direct care roles, and locations in which care is provided.

    Why it matters

    This paper describes the plan for sampling organisations and staff who care for people with dementia in the National Dementia Workforce Study. It is about research methods for studying the dementia care workforce and does not address treating, curing, or preventing the disease.

  10. Cardiometabolic disorders and mild cognitive impairment in White and Black Americans

    ✓ Peer-reviewed alzhub usefulness score 44 out of 100. Alzheimer s & Dementia 2025-09-01 Mild cognitive impairment

    Controlling for demographic/health variables, individuals with aMCI, though not naMCI, showed a higher likelihood of hypertension, diabetes, and hyperlipidemia compared to cognitively normal counterparts, though no differences between aMCI/naMCI.

    Why it matters

    People with amnestic mild cognitive impairment were more likely to have hypertension, diabetes and hyperlipidemia than cognitively normal counterparts, and Black Americans were more likely to fall into hypertension and diabetes groups regardless of cognitive status. The authors say this underscores the need for tailored interventions to address inequities and reduce the risk of progression to dementia.

  11. With this study, we will contribute nationally representative data on health, dementia and cognitive aging in Dominican Republic and Puerto Rico, as well as harmonized data in Cuba to expand understanding of aging and dementia in the Hispanic Caribbean and promote cross-national comparative research around the world.

    Why it matters

    This paper describes the protocol for a population-based study of older adult health and dementia in Cuba, the Dominican Republic, and Puerto Rico. It aims to contribute data on health, dementia, and cognitive aging, not to test a treatment or cure.

  12. Coverage and Prior Authorization Policies for Semaglutide and Tirzepatide in Medicare Part D Plans

    ✓ Peer-reviewed alzhub usefulness score 44 out of 100. JAMA Network Open 2025-08-29 Health systems and care delivery

    This cross-sectional study examines trends in coverage of glucagon-like peptide-1 receptor agonists, semaglutide and tirzepatide, and prior authorization requirements among Medicare Part D beneficiaries.

    Why it matters

    This study looked at how often Medicare Part D plans cover semaglutide and tirzepatide and what prior authorization rules they require. It provides no information on treating, curing or preventing Alzheimer's disease.

  13. Apolipoprotein E, Executive Function, and Falls across Cognitive Status: A Cross-Sectional Study

    ✓ Peer-reviewed alzhub usefulness score 44 out of 100. Dementia and Geriatric Cognitive Disorders 2025-08-21 Clinical safety

    ApoE4 did not moderate the EF and falls relationship (p ≥ 0.05).

    Why it matters

    In this cross-sectional study, the ApoE4 gene did not moderate the relationship between executive function and falls, but executive function was associated with fall history in people with unimpaired cognition and MCI, not in those with Alzheimer's dementia. The findings concern fall risk factors rather than treating, curing, or preventing the disease.

  14. The National Dementia Workforce Study: Methods for Surveying Community Clinicians Who Provide Care to People With Dementia

    ✓ Peer-reviewed alzhub usefulness score 44 out of 100. Journal of the American Geriatrics Society 2025-08-08 Caregiving

    People with dementia have complex medical, functional, and social needs and experience highly variable care quality and outcomes across the U.S. health care system.

    Why it matters

    This report describes the methods for a national survey of community clinicians who care for people with dementia, covering their training, practice, and job factors. It is a study plan rather than a treatment trial, so it does not show any effect on treating, curing, or preventing Alzheimer's disease.

  15. Impacts of Environmental Distractions and Interruptions on Unsupervised Digital Cognitive Assessments in Older Adults: Cognitive Ecological Momentary Assessment Study

    ✓ Peer-reviewed alzhub usefulness score 44 out of 100. JMIR mhealth and uhealth 2025-08-06 Getting a diagnosis

    Across all participants, momentary effects of environmental distractions were minimal.

    Why it matters

    This study found that environmental distractions had minimal effects on unsupervised digital cognitive assessments in older adults, with some effects depending on cognitive status. It is about the reliability of remote cognitive testing, not about treating, curing, or preventing Alzheimer's disease.

  16. A review of type 2 diabetes mellitus and cognitive impairment

    ✓ Peer-reviewed alzhub usefulness score 44 out of 100. Frontiers in Endocrinology 2025-08-04 Risk factors

    The association between type 2 diabetes mellitus (T2DM) and cognitive impairment represents a critical public health concern, particularly against the backdrop of the rising global prevalence of diabetes and aging populations.

    Why it matters

    This review reports that type 2 diabetes is linked to cognitive decline that may progress to dementia, through mechanisms including insulin resistance, inflammation, vascular injury and oxidative stress. It notes that strict blood sugar control plus lifestyle changes may delay cognitive decline, but says longer-term evidence is still needed.

  17. Mental and physical health of US rural/urban caregivers of persons with dementia

    ✓ Peer-reviewed alzhub usefulness score 44 out of 100. PLoS ONE 2025-08-01 Disparities

    Approximately, 25.7% of rural and 20.8% of urban caregivers reported ≥14 PMHD while 25% of rural and 10% of urban caregivers reported ≥14 PPHD.

    Why it matters

    This study found that rural caregivers of persons with dementia were less likely to experience short-term mental health problems than urban caregivers, but were significantly more likely to endure more physical health problems after adjustment. The findings concern caregiver health rather than treating, curing, or preventing Alzheimer's disease.

  18. Reliability of remote self-administered digital cognitive assessments: preliminary validation study

    ✓ Peer-reviewed alzhub usefulness score 44 out of 100. Frontiers in Digital Health 2025-07-03 Getting a diagnosis

    We found moderate or good agreement between self- and RC-administered performance, with intraclass correlation ranging from 0.59 to 0.83.

    Why it matters

    This preliminary validation study found moderate or good agreement between self-administered and remotely clinician-administered digital cognitive assessments, with no significant difference in performance. The results demonstrate the feasibility of remote self-administration using this platform.

  19. Lung ultrasound (LUS) as a predictor of delirium in elderly patients with COVID-19 during hospitalization: A geriatric vulnerability-stress model

    ✓ Peer-reviewed alzhub usefulness score 44 out of 100. Archives of Gerontology and Geriatrics Plus 2025-07-02 Clinical safety

    LUS and cognitive impairment are strong predictors of delirium in elderly COVID-19 patients.

    Why it matters

    This prospective study of elderly COVID-19 patients found that a lung ultrasound score above 3 and lower MMSE scores independently predicted delirium during hospitalisation. The authors suggest the lung ultrasound score provides an objective bedside measure of lung pathology severity linked to elevated delirium risk, and call for further validation.

  20. The Moderating Role of Dementia‐Related Fear in the Relationship Between Perceived Cognitive Decline and Motivation for Dementia Risk Reduction Behaviors in Community‐Dwelling Middle‐Aged and Older Adults

    ✓ Peer-reviewed alzhub usefulness score 44 out of 100. International Journal of Geriatric Psychiatry 2025-07-01 Prevention and risk

    A significant correlation was found between perceived cognitive decline and increased motivation to engage in dementia risk reduction behaviors (r = 0.44).

    Why it matters

    This cross-sectional study found that people who perceived their thinking was declining were more motivated to take up dementia risk reduction behaviors, but this motivation was weaker or absent when dementia-related fear was high. It suggests that public health messages should give people practical, actionable steps rather than emphasizing frightening aspects of dementia.

  21. Utilization Patterns and Clinical Factors Associated With Hospitalization in Early‐Stage Dementia With Lewy Bodies

    ✓ Peer-reviewed alzhub usefulness score 44 out of 100. International Journal of Geriatric Psychiatry 2025-07-01 Clinical safety

    Patients with DLB had significantly greater rates of hospitalization and ED visits compared to patients with AD (Incidence Rate Ratio (IRR): 1.46, 95% CI 1.24, 1.73, IRR: 1.46, 95% CI 1.29, 1.77, respectively) and controls (IRR: 1.77, 95% CI 1.46, 2.14, IRR: 2.21, 95% CI 1.82, 2.69, respectively) and ED visits compared to those with VD (IRR: 1.24, 95% CI 1.03, 1.50).

    Why it matters

    This study found that patients with early-stage dementia with Lewy bodies had higher rates of hospitalization and emergency department visits than patients with Alzheimer's disease, vascular dementia or controls, and were more likely to have falls-related hospitalizations. It suggests fall prevention and psychiatric treatment may help reduce hospitalizations but does not test any treatment, cure or prevention for Alzheimer's disease.

  22. Delirium in nursing homes and long-term care facilities: findings of a scoping review of detection tools

    ✓ Peer-reviewed alzhub usefulness score 44 out of 100. European Geriatric Medicine 2025-06-28 Clinical safety

    A total of 58 studies met the inclusion criteria, with most conducted in the USA (37.9%) and Europe.

    Why it matters

    This review found no standardised way to detect delirium in nursing homes and long-term care, and only some of the 25 tools identified had been tested for validity and reliability there. It recommends integrating screening into routine care and training staff, not a treatment for Alzheimer's disease.

  23. Análisis comparativo del efecto de las dietas mediterránea, cetogénica, DASH y MIND en la prevención del alzheimer

    ✓ Peer-reviewed alzhub usefulness score 44 out of 100. MLS Health & Nutrition Research 2025-06-19 Treatments

    The aim of this literature review is to examine and contrast four dietary patterns to evaluate their influence on Alzheimer's prevention.

    Why it matters

    This literature review reports that the Mediterranean, ketogenic, DASH, and MIND diets can all offer benefits in Alzheimer's prevention, with the MIND diet described as promising because it combines features of the Mediterranean and DASH diets. The authors state that choosing the most effective diet requires considering other approaches too, such as physical activity to improve cognitive decline.

  24. Perspectives and Experiences of Family Caregivers Using Supportive Mobile Apps in Dementia Care: Meta-Synthesis of Qualitative Research

    ✓ Peer-reviewed alzhub usefulness score 44 out of 100. JMIR mhealth and uhealth 2025-06-18 Caregiving

    A preliminary search yielded 4772 studies, of which 12 (0.25%) met the criteria.

    Why it matters

    This meta-synthesis of 12 qualitative studies found that family caregivers' use of supportive mobile apps is influenced by their perceived value of the apps and their caregiving burden, and that such apps can support caregiving abilities, emotions, social connections, and self-care. It identifies design barriers such as lack of technological literacy, time constraints, and privacy concerns.

  25. Exercise Prescription in Arrhythmogenic Cardiomyopathy: Finding the Right Balance Between Risks and Benefits

    ✓ Peer-reviewed alzhub usefulness score 44 out of 100. Journal of the American Heart Association 2025-06-05 Prevention and risk

    Arrhythmogenic cardiomyopathy (ACM) is an inherited cardiac condition, often caused by mutations in genes encoding desmosomal proteins.

    Why it matters

    This review is about arrhythmogenic cardiomyopathy, an inherited heart condition, and does not address treating, curing or preventing Alzheimer's disease. It discusses exercise risks and prescription for people with this heart condition.

From across this topic

10 of the 7,967 studies in this topic, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 10. The same 10 appear here every time.

Other topics